Compare AbCellera Biologics Inc (ABCL) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs United States Natural Gas Fund — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while United States Natural Gas Fund trades at $10.22. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| ABCL | UNG | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | Commodities - Energy |
52-Week High | $9.76 | $16.90 |
52-Week Low | $2.78 | $9.63 |
Enterprise Value | $2.58B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
